Correlation Between Enliven Therapeutics and Transcode Therapeutics
Can any of the company-specific risk be diversified away by investing in both Enliven Therapeutics and Transcode Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enliven Therapeutics and Transcode Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enliven Therapeutics and Transcode Therapeutics, you can compare the effects of market volatilities on Enliven Therapeutics and Transcode Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enliven Therapeutics with a short position of Transcode Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enliven Therapeutics and Transcode Therapeutics.
Diversification Opportunities for Enliven Therapeutics and Transcode Therapeutics
0.75 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Enliven and Transcode is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Enliven Therapeutics and Transcode Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Transcode Therapeutics and Enliven Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enliven Therapeutics are associated (or correlated) with Transcode Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Transcode Therapeutics has no effect on the direction of Enliven Therapeutics i.e., Enliven Therapeutics and Transcode Therapeutics go up and down completely randomly.
Pair Corralation between Enliven Therapeutics and Transcode Therapeutics
Given the investment horizon of 90 days Enliven Therapeutics is expected to generate 0.28 times more return on investment than Transcode Therapeutics. However, Enliven Therapeutics is 3.62 times less risky than Transcode Therapeutics. It trades about 0.04 of its potential returns per unit of risk. Transcode Therapeutics is currently generating about -0.02 per unit of risk. If you would invest 1,772 in Enliven Therapeutics on September 3, 2024 and sell it today you would earn a total of 666.00 from holding Enliven Therapeutics or generate 37.58% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Enliven Therapeutics vs. Transcode Therapeutics
Performance |
| Timeline |
| Enliven Therapeutics |
| Transcode Therapeutics |
Enliven Therapeutics and Transcode Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enliven Therapeutics and Transcode Therapeutics
The main advantage of trading using opposite Enliven Therapeutics and Transcode Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enliven Therapeutics position performs unexpectedly, Transcode Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Transcode Therapeutics will offset losses from the drop in Transcode Therapeutics' long position.| Enliven Therapeutics vs. DiaMedica Therapeutics | Enliven Therapeutics vs. Lyra Therapeutics | Enliven Therapeutics vs. Centessa Pharmaceuticals PLC |
| Transcode Therapeutics vs. Xenetic Biosciences | Transcode Therapeutics vs. Reviva Pharmaceuticals Holdings | Transcode Therapeutics vs. Eyenovia | Transcode Therapeutics vs. Cognition Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |